Alliqua Inc fka ALQA

[zino]

Board of Directors (SEEE Celgene Connections )

Dr. Jerome Zeldis, MD, PhD, Chairman of the Board of Directors

Dr. Jerome Zeldis is the Chief Medical Officer and President of Clinical Development at Sorrento Therapeutics (Nasdaq: SRNE), a biopharmaceutical company developing new treatments for cancer, pain management, inflammation, and autoimmune diseases. [color=red]Prior to joining Sorrento, Dr. Zeldis served as the Chief Medical Officer of Celgene Corporation (Nasdaq: CELG),

Winston Kung, Member, Board of Directors

Winston Kung is the Vice President of Business Development and Global Alliances at Celgene Corporation. He worked previously as the Chief Business Officer at Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation.[/b]
https://alliqua.com/about-us/board-of-directors/

CELGENE CORPORATION Owns 18.8%Includes 8,046,100 shares of Common Stock and 979,094 shares of Common Stock underlying warrants that are exercisable immediately ,The percentage ownership is based on 47,959,371 shares of Common Stock outstanding as of June 23, 2017

https://ih.advfn.com/p.php?pid=nmona&article=75124199